BAD Report 2014: Leprosy – could be misdiagnosed
Report from the British Association of Dermatologists annual meeting held in Glasgow from 30th June -3rd July 2014 by Christine Clark. Dermatologists from Cardiff warned that cases of… read more.
Report from the British Association of Dermatologists annual meeting held in Glasgow from 30th June -3rd July 2014 by Christine Clark. Dermatologists from Cardiff warned that cases of… read more.
An international research team led by Cesar A. Arias, M.D., Ph.D., at The University of Texas Health Science Center at Houston (UTHealth) has identified a new superbug that… read more.
World Health Matters: Sweden by Gary Finnegan – A newly discovered tick-borne bacterium known as Candidatus Neoehrlichia mikurensis has been implicated in six cases of disease in Sweden…. read more.
World Health Matters by Gary Finnegan – Australia – The number of deaths from viral hepatitis in Australia has surpassed the number of preventable AIDS-related deaths, according to… read more.
by Bruce Sylvester – Emerging uses of FDA approved drugs – Immunosuppresant drugs used to prevent organ rejection after transplantation could become used in fighting persistent HIV infection,… read more.
Enzyme’s role is to ‘throw away’ protein if it overstays its welcome during immune response. An enzyme that helps maintain immune system function by “throwing away” a specific… read more.
Maria Dalby reporting from the annual British Transplantation Society meeting in Glasgow by Anthony Dorling, King’s College London – Chronic rejection is a major cause of graft failure… read more.
A novel antiviral drug may protect people infected with the measles from getting sick and prevent them from spreading the virus to others, an international team of researchers… read more.
by Bruce Sylvester – Diflunisal, a generic anti-inflammatory drug, appears to reduce neurological decline and preserve quality-of-life in patients with familial transthyretin amyloidosis (ATTR).
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Length of infection increases risk for atherosclerosis. HIV infection, not antiretroviral therapy… read more.
by Bruce Sylvester – taken from The Lancet – An investigative, single-pill combination drug shows efficacy for treating patients with the most difficult-to-treat types of hepatitis C, researchers… read more.
Investigators reported on Oct. 22 in the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) that treatment with adalimumab may be effective for patients with steroid-resistant… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.